Drugs / Samarium 153
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00328614 | Mar 2003 → Feb 2009 | prostate cancer | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00551525 | Apr 2008 → Jul 2014 | prostate cancer | Radiation Therapy Oncology Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Samarium-153 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00328614 ↗ |
| Route | Intravenous | “by IV injection” NCT00551525 ↗ |